Cardio IQ Apolipoprotein Evaluation Biomarker Testing
It measures key apolipoproteins tied to atherosclerosis risk and treatment response, with convenient ordering and Quest-based lab access via Vitals Vault.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
This test looks beyond “cholesterol numbers” and measures the proteins that sit on lipoprotein particles (apolipoproteins). Those proteins help estimate how many atherogenic particles are circulating and how well your body is clearing them.
Cardio IQ Apolipoprotein Evaluation typically includes apolipoprotein B (ApoB) and apolipoprotein A1 (ApoA1), plus the ApoB/ApoA1 ratio. Together, they can clarify risk when LDL-C looks “fine,” when triglycerides are high, or when you are tracking response to lifestyle changes or lipid-lowering therapy.
Your result is one piece of cardiovascular risk. It is most useful when you interpret it alongside your overall history, blood pressure, glucose/insulin markers, and other lipid tests with a clinician.
Do I need a Cardio IQ Apolipoprotein Evaluation test?
You may consider this test if your standard lipid panel does not match your real-world risk picture. For example, you might have a “normal” LDL cholesterol (LDL-C) but a strong family history of early heart disease, metabolic syndrome, type 2 diabetes, fatty liver, or persistently high triglycerides.
It can also be helpful if you are already working on risk reduction and want a marker that tracks particle burden more directly than LDL-C. ApoB often changes in a clearer direction when you adjust diet quality, lose weight, treat hypothyroidism, or start or adjust lipid-lowering medications.
You may also want it if you have discordant results, such as low HDL-C with high triglycerides, or if you have had a coronary calcium scan or other imaging that suggests plaque despite “acceptable” cholesterol.
Testing supports clinician-directed care and shared decision-making, but it cannot diagnose atherosclerosis or predict events on its own.
This is a blood test run in a CLIA-certified laboratory; results should be interpreted in clinical context and are not a standalone diagnosis of cardiovascular disease.
Lab testing
Order labs to measure Cardio IQ Apolipoprotein Evaluation
from $29.99 at Quest Diagnostics
About 1 week
Schedule online — results typically within a week
Clear next steps
Guidance included, with follow-up care available
HSA / FSA
Eligible for pre-tax health spending accounts
Get this test with Vitals Vault
Vitals Vault lets you order Cardio IQ Apolipoprotein Evaluation directly, so you can move from “I’m not sure what my cholesterol means” to a clearer, more actionable risk discussion.
After your blood draw, you can use PocketMD to review what ApoB, ApoA1, and the ApoB/ApoA1 ratio suggest in your situation, what companion labs commonly add clarity, and what retesting timeline makes sense for your plan.
If you are monitoring change, Vitals Vault makes it straightforward to reorder the same test so you can compare trends over time rather than guessing from a single snapshot.
- Order online and complete your blood draw through a national lab network
- PocketMD helps you translate results into next-step questions for your clinician
- Easy re-testing to track response to lifestyle or medication changes
Key benefits of Cardio IQ Apolipoprotein Evaluation testing
- Estimates atherogenic particle burden more directly than LDL-C by measuring ApoB.
- Helps explain “discordant” lipid patterns, such as normal LDL-C with high triglycerides or insulin resistance.
- Adds context for cardiovascular risk discussions when family history suggests higher baseline risk.
- Supports therapy monitoring by showing whether particle-related risk is improving with diet, weight loss, or medications.
- Provides the ApoB/ApoA1 ratio, a simple summary of pro-atherogenic versus protective lipoprotein balance.
- Pairs well with other advanced markers (like Lp(a) or hs-CRP) to build a more complete risk picture.
- Creates a clear baseline you can trend over time, especially when you retest consistently.
What is Cardio IQ Apolipoprotein Evaluation?
Cardio IQ Apolipoprotein Evaluation is an advanced lipid-related blood test that measures apolipoproteins—proteins that act like “ID tags” on lipoprotein particles. The most common components are apolipoprotein B (ApoB) and apolipoprotein A1 (ApoA1), often reported with the ApoB/ApoA1 ratio.
ApoB is found on atherogenic particles that can enter the artery wall, including LDL, VLDL remnants, and other ApoB-containing particles. Because each of these particles generally carries one ApoB molecule, ApoB is often used as a proxy for the number of atherogenic particles.
ApoA1 is the main protein on HDL particles, which are involved in reverse cholesterol transport and other protective functions. The ApoB/ApoA1 ratio compares these opposing directions—more ApoB relative to ApoA1 generally points toward higher atherogenic risk.
Unlike LDL-C, which estimates the amount of cholesterol carried inside LDL particles, ApoB is more about particle count. Two people can have the same LDL-C but very different ApoB, especially when triglycerides are elevated or when LDL particles are smaller and more numerous.
How this differs from a standard lipid panel
A standard lipid panel reports total cholesterol, LDL-C, HDL-C, and triglycerides. Those are useful, but they can miss situations where cholesterol content per particle is low while particle number is high. ApoB helps uncover that mismatch, which is common in insulin resistance and hypertriglyceridemia.
When the ApoB/ApoA1 ratio is especially useful
The ratio can be a quick way to summarize balance: higher ApoB (more atherogenic particles) and/or lower ApoA1 (less protective capacity) pushes the ratio up. It is not a replacement for a full risk assessment, but it can help you and your clinician decide whether to intensify lifestyle changes, add companion testing, or revisit treatment targets.
What do my Cardio IQ Apolipoprotein Evaluation results mean?
Low ApoB and/or low ApoA1
A low ApoB level generally suggests fewer atherogenic particles, which is often favorable from a cardiovascular risk standpoint. A low ApoA1 can be less favorable because it may reflect lower HDL particle-related protective capacity, although HDL biology is complex and not all “low HDL” patterns carry the same meaning. If ApoA1 is low, your clinician may look at triglycerides, insulin resistance markers, smoking status, and inflammation as potential contributors. Very low apolipoproteins can also occur with certain genetic conditions or severe illness, so context matters.
Optimal (in-range) ApoB, ApoA1, and ratio
An in-range ApoB and a balanced ApoB/ApoA1 ratio generally suggest that your particle-related lipid risk is not elevated relative to the lab’s reference interval. This is most reassuring when it matches the rest of your risk profile, including blood pressure, glucose control, and family history. If you are on treatment, “optimal” can indicate that your current plan is working, especially if the trend is improving over time. Your clinician may still individualize targets if you have known plaque, diabetes, or very high baseline risk.
High ApoB and/or high ApoB/ApoA1 ratio
A high ApoB level suggests a higher number of atherogenic particles circulating in your blood, which can increase the likelihood of cholesterol deposition in artery walls over time. A high ApoB/ApoA1 ratio often means the balance is shifted toward atherogenic particles relative to protective HDL-related proteins. This pattern is common with insulin resistance, high triglycerides, obesity, hypothyroidism, and some genetic lipid disorders. A high result is a prompt to review lifestyle, secondary causes, and whether additional testing or treatment targets should be discussed with your clinician.
Factors that influence apolipoproteins
ApoB can rise with insulin resistance, higher triglycerides, diets that promote excess calorie intake, untreated hypothyroidism, kidney disease, and certain genetic patterns. ApoA1 can be affected by smoking, inflammation, physical activity level, and metabolic health, and it may shift with weight change and alcohol intake. Medications (such as statins, ezetimibe, PCSK9 inhibitors, fibrates, and some hormones) can change ApoB and ApoA1 in different directions. Because recent illness, major diet changes, and rapid weight loss can temporarily shift lipids, retesting is often most meaningful after your routine has been stable for several weeks.
What’s included
- Apolipoprotein A1
- Apolipoprotein B
- Apolipoprotein B/A1 Ratio
Similar tests and related panels
Frequently Asked Questions
Is ApoB better than LDL cholesterol?
ApoB and LDL-C answer different questions. LDL-C estimates how much cholesterol is carried in LDL particles, while ApoB estimates how many atherogenic particles you have. If your LDL-C and ApoB are “discordant” (for example, LDL-C looks fine but ApoB is high), ApoB may better reflect particle-related risk, especially when triglycerides are elevated or insulin resistance is present.
What is a good ApoB/ApoA1 ratio?
Labs report reference intervals that can vary by method and population, so the best approach is to use your report’s range and discuss individualized targets with your clinician. In general, a lower ratio is more favorable because it reflects fewer atherogenic particles (ApoB) relative to protective HDL-related proteins (ApoA1). The ratio is most useful when you track it alongside ApoB itself and your overall risk profile.
Do I need to fast for an apolipoprotein test?
Many labs can measure ApoB and ApoA1 without fasting, because apolipoproteins are less meal-sensitive than triglycerides. However, your clinician may still prefer a fasting draw if you are also checking triglycerides or other lipid markers at the same time. If you are unsure, follow the collection instructions provided with your order.
How often should I retest ApoB and ApoA1?
A common approach is to retest about 8–12 weeks after a meaningful change, such as starting or adjusting lipid-lowering medication or making sustained diet and weight changes. If you are stable and using the test for periodic monitoring, your clinician may suggest less frequent checks. Trend interpretation is strongest when your testing conditions (fasting status, timing, and medication routine) are consistent.
Can ApoB be high even if my LDL is normal?
Yes. LDL-C can look normal when each LDL particle carries less cholesterol, but the number of particles is still high. This is more common with high triglycerides, insulin resistance, and smaller, more numerous LDL particles. ApoB helps reveal that pattern.
What other tests go well with Cardio IQ Apolipoprotein Evaluation?
Common companions include a standard lipid panel (to compare LDL-C and triglycerides), lipoprotein(a) [Lp(a)] for inherited risk, hs-CRP for inflammation, and glucose/insulin markers such as fasting glucose, HbA1c, and fasting insulin. Your clinician may also look for secondary causes with thyroid testing or kidney and liver markers when ApoB is unexpectedly high.